206 related articles for article (PubMed ID: 9448551)
1. The effects of improved glycemic control on complications in type 2 diabetes.
Gaster B; Hirsch IB
Arch Intern Med; 1998 Jan; 158(2):134-40. PubMed ID: 9448551
[TBL] [Abstract][Full Text] [Related]
2. Diabetic complications. The importance of glucose control.
Skyler JS
Endocrinol Metab Clin North Am; 1996 Jun; 25(2):243-54. PubMed ID: 8799699
[TBL] [Abstract][Full Text] [Related]
3. Relation of glycemic control to diabetic complications and health outcomes.
Klein R; Klein BE
Diabetes Care; 1998 Dec; 21 Suppl 3():C39-43. PubMed ID: 9850488
[TBL] [Abstract][Full Text] [Related]
4. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients.
Asakawa H; Tokunaga K; Kawakami F
J Diabetes Complications; 2000; 14(6):307-13. PubMed ID: 11120454
[TBL] [Abstract][Full Text] [Related]
5. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
Sjöholm A
Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
[TBL] [Abstract][Full Text] [Related]
6. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
7. Glycemic control and complications in type 2 diabetes mellitus.
Stolar M
Am J Med; 2010 Mar; 123(3 Suppl):S3-11. PubMed ID: 20206730
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
Haffner SM
Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
[TBL] [Abstract][Full Text] [Related]
9. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
[No Abstract] [Full Text] [Related]
10. The effect of glycemic control on the incidence of macrovascular complications of type 2 diabetes.
Stern MP
Arch Fam Med; 1998; 7(2):155-62. PubMed ID: 9519921
[TBL] [Abstract][Full Text] [Related]
11. Potential of glucose-lowering drugs to reduce cardiovascular events.
Zarich SW
Curr Diab Rep; 2009 Feb; 9(1):87-94. PubMed ID: 19192430
[TBL] [Abstract][Full Text] [Related]
12. [Good glycaemic control can prevent diabetic peripheral neuropathy].
Gregersen S
Ugeskr Laeger; 2013 Sep; 175(36):2022-5. PubMed ID: 23992909
[TBL] [Abstract][Full Text] [Related]
13. Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.
Giugliano D; Maiorino MI; Bellastella G; Esposito K
Endocrine; 2018 Jul; 61(1):23-27. PubMed ID: 29322300
[TBL] [Abstract][Full Text] [Related]
14. Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia.
Demoz GT; Gebremariam A; Yifter H; Alebachew M; Niriayo YL; Gebreslassie G; Woldu G; Bahrey D; Shibeshi W
BMC Res Notes; 2019 Apr; 12(1):207. PubMed ID: 30947749
[TBL] [Abstract][Full Text] [Related]
15. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
Cerveny JD; Leder RD; Weart CW
Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
[TBL] [Abstract][Full Text] [Related]
16. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
Weiss IA; Valiquette G; Schwarcz MD
Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of microvascular and neuropathic complications of diabetes.
Eastman RC; Garfield SA
Prim Care; 1999 Dec; 26(4):791-807. PubMed ID: 10523460
[TBL] [Abstract][Full Text] [Related]
18. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
Ma J; Yang W; Fang N; Zhu W; Wei M
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
[TBL] [Abstract][Full Text] [Related]
19. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.
Terry T; Raravikar K; Chokrungvaranon N; Reaven PD
Curr Cardiol Rep; 2012 Feb; 14(1):79-88. PubMed ID: 22160862
[TBL] [Abstract][Full Text] [Related]
20. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study.
Mohan V; Shah S; Saboo B
J Assoc Physicians India; 2013 Jan; 61(1 Suppl):12-5. PubMed ID: 24482981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]